title: Brain metabolism of exogenous pyruvate.
abstract: Pyruvate given in large doses may be neuroprotective in stroke, but it is not known to what degree the brain metabolizes pyruvate. Intravenous injection of [3-13C]pyruvate led to dose-dependent labelling of cerebral metabolites so that at 5 min after injection of 18 mmoles [3-13C]pyruvate/kg (2 g sodium pyruvate/kg), approximately 20% of brain glutamate and GABA were labelled, as could be detected by 13C nuclear magnetic resonance spectrometry ex vivo. Pyruvate, 9 mmoles/kg, was equivalent to glucose, 9 mmoles/kg, as a substrate for cerebral tricarboxylic acid (TCA) cycle activity. Inhibition of the glial TCA cycle with fluoroacetate did not affect formation of [4-13C]glutamate or [2-13C]GABA from [3-13C]pyruvate, but reduced formation of [4-13C]glutamine by 50%, indicating predominantly neuronal metabolism of exogenous pyruvate. Extensive formation of [3-13C]lactate from [2-13C]pyruvate demonstrated reversible carboxylation of pyruvate to malate and equilibration with fumarate, presumably in neurones, but anaplerotic formation of TCA cycle intermediates from exogenous pyruvate could not be detected. Too rapid injection of large amounts of pyruvate led to seizure activity, respiratory arrest and death. We conclude that exogenous pyruvate is an excellent energy substrate for neurones in vivo, but that care must be taken to avoid the seizure-inducing effect of pyruvate given in large doses.
authors.affiliation: Norwegian Defence Research Establishment, Kjeller, Norway.
authors.forename: Susana Villa
authors.initials: SV
authors.lastname: Gonzalez
authors.forename: Nga H T
authors.initials: NH
authors.lastname: Nguyen
authors.forename: Frode
authors.initials: F
authors.lastname: Rise
authors.forename: Bjørnar
authors.initials: B
authors.lastname: Hassel
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001769:Blood / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D004734:Energy Metabolism; D005215:Fasting / Q000378:metabolism; D005260:Female; D005463:Fluoroacetates / Q000494:pharmacology; D005947:Glucose / Q000008:administration & dosage / Q000378:metabolism; D007275:Injections, Intravenous; D019344:Lactic Acid / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008293:Malates / Q000378:metabolism; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D011773:Pyruvates / Q000008:administration & dosage / Q000378:metabolism*; D012640:Seizures / Q000139:chemically induced / Q000175:diagnosis; D013997:Time Factors
chemical_list: D005463:Fluoroacetates; D008293:Malates; D011773:Pyruvates; D019344:Lactic Acid; C030298:malic acid; D005947:Glucose